Literature DB >> 17105890

Beta blocker treatment is associated with improvement in renal function and anaemia in patients with heart failure.

W Khan, S M Deepak, T Coppinger, C Waywell, A Borg, L Harper, S G Williams, N H Brooks.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17105890      PMCID： PMC1861276          DOI： 10.1136/hrt.2005.083998

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  8 in total

1.  Results from post-hoc analyses of the CIBIS II trial: effect of bisoprolol in high-risk patient groups with chronic heart failure.

Authors:  E Erdmann; P Lechat; P Verkenne; H Wiemann
Journal:  Eur J Heart Fail       Date:  2001-08       Impact factor: 15.534

2.  Renal function, neurohormonal activation, and survival in patients with chronic heart failure.

Authors:  H L Hillege; A R Girbes; P J de Kam; F Boomsma; D de Zeeuw; A Charlesworth; J R Hampton; D J van Veldhuisen
Journal:  Circulation       Date:  2000-07-11       Impact factor: 29.690

3.  Blunted erythropoietin production and defective iron supply for erythropoiesis as major causes of anaemia in patients with chronic heart failure.

Authors:  Cristina Opasich; Mario Cazzola; Laura Scelsi; Stefania De Feo; Enzo Bosimini; Rocco Lagioia; Oreste Febo; Roberto Ferrari; Alessandro Fucili; Remigio Moratti; Roberto Tramarin; Luigi Tavazzi
Journal:  Eur Heart J       Date:  2005-06-29       Impact factor: 29.983

4.  Beta-blockers are associated with lower C-reactive protein concentrations in patients with coronary artery disease.

Authors:  Nicholas P Jenkins; Brian G Keevil; Ian V Hutchinson; Nicholas H Brooks
Journal:  Am J Med       Date:  2002-03       Impact factor: 4.965

5.  Role of the kidney in congestive heart failure. Relationship of cardiac index to kidney function.

Authors:  S Ljungman; J H Laragh; R J Cody
Journal:  Drugs       Date:  1990       Impact factor: 9.546

6.  Relationship between central hemodynamics and regional blood flow in normal subjects and in patients with congestive heart failure.

Authors:  M E Leithe; R D Margorien; J B Hermiller; D V Unverferth; C V Leier
Journal:  Circulation       Date:  1984-01       Impact factor: 29.690

Review 7.  Hematocrit-lowering effect following inactivation of renin-angiotensin system with angiotensin converting enzyme inhibitors and angiotensin receptor blockers.

Authors:  K P Marathias; B Agroyannis; T Mavromoustakos; J Matsoukas; D V Vlahakos
Journal:  Curr Top Med Chem       Date:  2004       Impact factor: 3.295

8.  Anemia and renal insufficiency are independent risk factors for death among patients with congestive heart failure admitted to community hospitals: a population-based study.

Authors:  William M McClellan; W Dana Flanders; Robert D Langston; Claudine Jurkovitz; Rodney Presley
Journal:  J Am Soc Nephrol       Date:  2002-07       Impact factor: 10.121
  8 in total
  3 in total

1.  Comorbid Heart Failure and Renal Impairment: Epidemiology and Management.

Authors:  Pupalan Iyngkaran; Merlin Thomas; William Majoni; Nagesh S Anavekar; Claudio Ronco
Journal:  Cardiorenal Med       Date:  2012-10-31       Impact factor: 2.041

Review 2.  Pharmacologic management of the cardiorenal syndrome in heart failure.

Authors:  Henry Krum; Pupalan Iyngkaran; Suree Lekawanvijit
Journal:  Curr Heart Fail Rep       Date:  2009-06

3.  Efficacy and safety of nebivolol in elderly heart failure patients with impaired renal function: insights from the SENIORS trial.

Authors:  Alain Cohen-Solal; Dipak Kotecha; Dirk J van Veldhuisen; Daphne Babalis; Michael Böhm; Andrew J Coats; Michael Roughton; Philip Poole-Wilson; Luigi Tavazzi; Marcus Flather
Journal:  Eur J Heart Fail       Date:  2009-08-01       Impact factor: 15.534
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.